Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: A cost-benefit analysis

European Journal of Heart Failure

Volumn 9, Issue 12, 2007, Pages 1186-1195

  Goode, Kevin M ^a   Clark, Andrew L ^a   Bristow, Janet A ^a   Sykes, Kim B ^a   Cleland, John G F ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Cost benefit analysis; Electrocardiogram; Left ventricular systolic dysfunction; Natriuretic peptides; Primary care; Screening

Indexed keywords

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; SOCIOECONOMICS; STATISTICAL ANALYSIS;

AGED; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MASS SCREENING; MYOCARDIAL CONTRACTION; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 36248976605     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.10.003     Document Type: Article

References (31)

1. Davies M., Hobbs F., Davis R., et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 358 (2001) 439-444
2. McDonagh T.A., Morrison C.E., Lawrence A., et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350 (1997) 829-833
3. Hobbs F.D., Davis R.C., Roalfe A.K., Hare R., and Davies M.K. Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations. Heart 90 (2004) 866-870
4. Galasko G.I., Barnes S.C., Collinson P., Lahiri A., and Senior R. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?. Eur Heart J 27 (2005) 193-200
5. Cleland J.G., and Clark A.L. Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth. J Am Coll Cardiol 42 (2003) 1234-1237
6. Cleland J.G., Cohen-Solal A., Aguilar J.C., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360 (2002) 1631-1639
7. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
8. Heidenreich P.A., Gubens M.A., Fonarow G.C., Konstam M.A., Stevenson L.W., and Shekelle P.G. Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. J Am Coll Cardiol 43 (2004) 1019-1026
9. McMurray J.V., McDonagh T.A., Davie A.P., Cleland J.G., Francis C.M., and Morrison C. Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?. Eur Heart J 19 (1998) 842-846
10. Baker D.W., Bahler R.C., Finkelhor R.S., and Lauer M.S. Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure. Am Heart J 146 (2003) 736-740
11. Ng L.L., Loke I., Davies J.E., et al. Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography. Eur J Heart Fail 5 (2003) 775-782
12. Hobbs F.D.R., Davis R.C., Roalfe A.K., Hare R., Davies M.K., and Kenkre J.E. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 324 (2002) 1498-1500A
13. Mosterd A., de Bruijne M.C., Hoes A.W., Deckers J.W., Hofman A., and Grobbee D.E. Usefulness of echocardiography in detecting left ventricular dysfunction in population-based studies (The Rotterdam Study). Am J Cardiol 79 (1997) 103-104
14. Hedberg P., Lönnberg I., Jonason T., Nilsson G., Pehrsson K., and Ringqvist I. Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year old men and women. Am Heart J 148 (2004) 524-529
15. Murkofsky R.L., Dangas G., Diamond J.A., Mehta D., Schaffer A., and Ambrose J.A. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction. J Am Coll Cardiol 32 (1998) 476-482
16. Khan N.K., Goode K.M., Cleland J.G., et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail 9 (2007) 491-501
17. Kruger S., Filzmaier K., Graf J., et al. QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction. J Intern Med 255 (2004) 206-212
18. Sakhuja R., Chen A.A., Anwaruddin S., Baggish A.L., and Januzzi Jr. J.L. Combined use of amino terminal-pro-brain natriuretic peptide levels and QRS duration to predict left ventricular systolic dysfunction in patients with dyspnea. Am J Cardiol 96 (2005) 263-266
19. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333 (1995) 1670-1676
20. Galasko G.I., Lahiri A., Barnes S.C., Collinson P., and Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?. Eur Heart J 26 (2005) 2269-2276
21. Collinson P.O. The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspective. Congest Heart Fail 12 (2006) 103-107
22. Efron B., and Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1 (1986) 54-77
23. Goode KM, Cleland JG, Clark AL. Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width. Int J Cardiol in press.
24. McClure S.J., Caruana L., Davie A.P., Goldthorp S., and McMurray J.J. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ 317 (1998) 516-519
25. Mueller T., Gegenhuber A., Poelz W., and Haltmayer M. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Clin Chim Acta 341 (2004) 41-48
26. Renshaw A.A. Measuring sensitivity in gynecologic cytology: a review. Cancer 96 (2002) 210-217
27. Van de W.F., Ardissino D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
28. Bertrand M.E., Simoons M.L., Fox K.A., et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 21 (2000) 1406-1432
29. Torabi A., Khan N.K., and Cleland J.G.F. Contemporary epidemiology of left ventricular systolic dysfunction after myocardial infarction. Eur J Heart Fail Supplements 6 (2007) A333 Heart Failure Congress, 9-12 June
30. Lim T.K., Collinson P.O., Celik E., Gaze D., and Senior R. Value of primary care electrocardiography for the prediction of left ventricular systolic dysfunction in patients with suspected heart failure. Int J Cardiol 115 (2006) 73-74
31. Jeyaseelan S., Goudie B.M., Pringle S.D., Donnan P.T., Sullivan F.M., and Struthers A.D. A critical re-appraisal of different ways of selecting ambulatory patients with suspected heart failure for echocardiography. Eur J Heart Fail 9 (2007) 55-61